These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 11489490

  • 1. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic.
    Duncan R, Gac-Breton S, Keane R, Musila R, Sat YN, Satchi R, Searle F.
    J Control Release; 2001 Jul 06; 74(1-3):135-46. PubMed ID: 11489490
    [Abstract] [Full Text] [Related]

  • 2. Development of HPMA copolymer-anticancer conjugates: clinical experience and lessons learnt.
    Duncan R.
    Adv Drug Deliv Rev; 2009 Nov 12; 61(13):1131-48. PubMed ID: 19699249
    [Abstract] [Full Text] [Related]

  • 3. PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.
    Satchi R, Connors TA, Duncan R.
    Br J Cancer; 2001 Sep 28; 85(7):1070-6. PubMed ID: 11592781
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Gamma scintigraphy of a 123I-labelled N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate containing galactosamine following intravenous administration to nude mice bearing hepatic human colon carcinoma.
    Pimm MV, Perkins AC, Strohalm J, Ulbrich K, Duncan R.
    J Drug Target; 1996 Sep 28; 3(5):385-90. PubMed ID: 8866657
    [Abstract] [Full Text] [Related]

  • 8. Designing polymer conjugates as lysosomotropic nanomedicines.
    Duncan R.
    Biochem Soc Trans; 2007 Feb 28; 35(Pt 1):56-60. PubMed ID: 17233601
    [Abstract] [Full Text] [Related]

  • 9. Pronounced Cellular Uptake of Pirarubicin versus That of Other Anthracyclines: Comparison of HPMA Copolymer Conjugates of Pirarubicin and Doxorubicin.
    Nakamura H, Koziolová E, Chytil P, Tsukigawa K, Fang J, Haratake M, Ulbrich K, Etrych T, Maeda H.
    Mol Pharm; 2016 Dec 05; 13(12):4106-4115. PubMed ID: 27934482
    [Abstract] [Full Text] [Related]

  • 10. Do HPMA copolymer conjugates have a future as clinically useful nanomedicines? A critical overview of current status and future opportunities.
    Duncan R, Vicent MJ.
    Adv Drug Deliv Rev; 2010 Feb 17; 62(2):272-82. PubMed ID: 20005271
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
    Searle F, Gac-Breton S, Keane R, Dimitrijevic S, Brocchini S, Sausville EA, Duncan R.
    Bioconjug Chem; 2001 Feb 17; 12(5):711-8. PubMed ID: 11562189
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data.
    Ríhová B, Strohalm J, Prausová J, Kubácková K, Jelínková M, Rozprimová L, Sírová M, Plocová D, Etrych T, Subr V, Mrkvan T, Kovár M, Ulbrich K.
    J Control Release; 2003 Aug 28; 91(1-2):1-16. PubMed ID: 12932633
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M, Strohalm J, Chytil P, Lidický O, Tomala J, Říhová B, Etrych T.
    J Control Release; 2017 Jan 28; 246():1-11. PubMed ID: 27940304
    [Abstract] [Full Text] [Related]

  • 18. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
    Etrych T, Subr V, Laga R, Ríhová B, Ulbrich K.
    Eur J Pharm Sci; 2014 Jul 16; 58():1-12. PubMed ID: 24632485
    [Abstract] [Full Text] [Related]

  • 19. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
    Shamay Y, Golan M, Tyomkin D, David A.
    J Control Release; 2016 May 10; 229():192-199. PubMed ID: 27001892
    [Abstract] [Full Text] [Related]

  • 20. Properties of HPMA copolymer-doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification.
    Chytil P, Etrych T, Konák C, Sírová M, Mrkvan T, Ríhová B, Ulbrich K.
    J Control Release; 2006 Sep 28; 115(1):26-36. PubMed ID: 16899320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.